Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

In a Medium interview, Professor Matthew Wood, a professor of Neuroscience in the Department of Paediatrics, talks about his work and the advances that a new Rare Diseases Centre could herald for the future of rare disease and genetics.

A new frontier in the fight against rare diseases

On Rare Diseases Day 2019, the University of Oxford and Harrington Discovery Institute at University Hospitals have announced a new affiliation to advance therapies for rare diseases.

The Oxford-Harrington Rare Disease Centre will bring together the capabilities, resources and expertise of both institutions to deliver new treatments for rare diseases, for which therapeutic options are lacking.

More than 350 million people worldwide are living with a rare disease, and approximately 50 percent of those are children. Here, we speak to Professor Matthew Wood, a professor of Neuroscience in the Department of Paediatrics, about his work and the advances that a new Rare Diseases Centre could herald for the future of rare disease and genetics.

Read more (Medium website)

Oxford-Harrington Rare Disease Centre news story (University of Oxford website)